CORRECT: Mony reports low single-digit revenue growth
21st Jul 2026 13:36
Corrects Mony's adjusted Ebitda for the first half of 2025 to GBP75.1 million. Read More
| Price | 501.50p on 28-07-2026 at 18:35:09 |
|---|---|
| Change | 10.50p 2.14% |
| Buy | 507.00p |
| Sell | 505.50p |
| Last Trade: | Unknown 16,804.00 at 501.50p |
| Day's Volume: | 6,312,809 |
| Last Close: | 501.50p |
| Open: | 496.00p |
| ISIN: | GB00B0WMWD03 |
| Day's Range | 492.60p - 507.50p |
| 52wk Range: | 398.60p - 551.00p |
| Market Capitalisation: | £2.57b |
| VWAP: | 500.13261p |
| Shares in Issue: | 512.47m |
Qinetiq (QQ.) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 16,804 | 501.50p | OTC Trade |
17:08:51 - 28-Jul-26 |
| Unknown* | 1,689,936 | 496.00p | Negotiated Trade OTC Trade |
16:49:32 - 28-Jul-26 |
| Buy* | 14,047 | 504.712p | SI Trade Negotiated Trade |
16:47:05 - 28-Jul-26 |
| Buy* | 3,431,231 | 501.50p | Suspected BUY Trade |
16:35:24 - 28-Jul-26 |
| Buy* | 123 | 506.00p | Automatic Execution |
16:29:45 - 28-Jul-26 |
| Buy* | 500 | 506.00p | Automatic Execution |
16:29:45 - 28-Jul-26 |
| Buy* | 323 | 506.00p | Automatic Execution |
16:29:45 - 28-Jul-26 |
| Buy* | 148 | 506.00p | Automatic Execution |
16:29:44 - 28-Jul-26 |
| Buy* | 153 | 506.00p | Automatic Execution |
16:29:40 - 28-Jul-26 |
| Sell* | 80 | 505.50p | Automatic Execution |
16:29:20 - 28-Jul-26 |
Qinetiq (QQ.) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 27th Jul 2026 5:13 pm | RNS | Holding(s) in Company |
| 21st Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 16th Jul 2026 1:09 pm | RNS | Result of AGM |
| 16th Jul 2026 7:00 am | RNS | Q1 Trading Update |
| 14th Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 10th Jul 2026 1:42 pm | RNS | Director/PDMR Shareholding |
| 7th Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 6th Jul 2026 9:21 am | RNS | Holding(s) in Company |
| 2nd Jul 2026 4:35 pm | RNS | Director/PDMR Shareholding |